News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
221 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (31)
2 (29)
3 (279)
4 (239)
5 (185)
6 (219)
7 (134)
8 (5)
9 (2)
10 (218)
11 (255)
12 (223)
13 (194)
14 (151)
15 (4)
16 (14)
17 (221)
18 (253)
19 (211)
20 (239)
21 (133)
22 (2)
23 (4)
24 (22)
25 (1)
26 (55)
27 (85)
28 (60)
30 (1)
31 (34)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
31
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab)
The product is a biosimilar candidate of Perjeta® (pertuzumab) currently in preclinical development.
December 17, 2018
·
3 min read
Biotech Beach
Cryoport Announces $25 Million Investment from Petrichor Healthcare Capital Management
Petrichor purchased $10 million of Cryoport common shares at a price per share of $10.00.
December 17, 2018
·
6 min read
Policy
Safe Food for Canadians Licences now Available for Food Businesses
These regulations will protect Canadian families by making the food system even safer by focusing on prevention and allowing for faster removal of unsafe food from the marketplace.
December 17, 2018
·
3 min read
Business
Abbott Hosts Conference Call for 2018 Fourth-Quarter Earnings
An archived edition of the call will be available later that day.
December 17, 2018
·
1 min read
Pharm Country
Bayer Updates Betaseron (interferon beta-1b) Prescribing Information in Accordance with the U.S. Food and Drug Administration’s Pregnancy and Lactation Labeling Rule
Bayer announced today that the Food and Drug Administration (FDA) has approved the inclusion of new safety data on pregnancy in the prescribing information for Betaseron® (Interferon beta 1b, IFNß-1b), which is indicated for the treatment of relapsing remitting multiple sclerosis (RRMS).
December 17, 2018
·
10 min read
Pharm Country
Balance 3H Plus Expands to New York City
Harrison-based Balance 3H Plus, a leading, doctor-supervised total health program that provides hormonal balance solutions for women 40 and older, has expanded to New York City.
December 17, 2018
·
3 min read
Genetown
Trinity Partners Announces Findings from FDA-Approved Drug Performance Index
Therapies for breast cancer, multiple myeloma, and HIV ranked the highest across audit of commercial performance, therapeutic value, and R&D complexity.
December 17, 2018
·
3 min read
Pharm Country
Instem Reports Increased Market Demand for KnowledgeScan Target Safety Assessment Service
Pioneering Service Delivers Comprehensive Insight into Biological Target Profiling
December 17, 2018
·
2 min read
Deals
Alira Health adds data science capabilities through acquisition of Clinical Insights.
Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announced that it has acquired Clinical Insights, a data science organization providing data analytics and predictive analysis to healthcare companies.
December 17, 2018
·
3 min read
Pharm Country
CareCredit Now Integrated Into Henry Schein’s Dental And Veterinary Practice Management Software Solutions
Henry Schein, Inc. (Nasdaq: HSIC) and CareCredit, a Synchrony (NYSE:SYF) solution and a leading provider of patient financing, today announced the integration of CareCredit’s financing tool into Henry Schein’s dental and veterinary practice management software solutions.
December 17, 2018
·
4 min read
Previous
16 of 23
Next